In vivo comparative therapeutic study of optimal administration of 5-fluorouracil and cisplatin using a newly established HST-1 human squamous-carcinoma cell line

Cancer Chemotherapy and Pharmacology

Volumn 29, Issue 4, 1992, Pages 273-276

  Kuroki, Mika ^a   Nakano, Shuji ^a   Mitsugi, Kenji ^a   Ichinose, Ichiro ^a   Anzai, Keizo ^a   Nakamura, Minoru ^a   Nagafuchi, Seiho ^a   Niho, Yoshiyuki ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CREATININE; FLUOROURACIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CELL; BODY WEIGHT; CANCER CELL CULTURE; CANCER GRAFT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFICACY; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ANIMAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMPARATIVE STUDY; DRUG SCREENING ASSAYS, ANTITUMOR; FLUOROURACIL; HUMAN; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; SUPPORT, NON-U.S. GOV'T; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0026518341     PISSN: 03445704     EISSN: 14320843     Source Type: Journal    
DOI: 10.1007/BF00685944     Document Type: Article

References (17)

1. Treatment of squamous-cell carcinoma of the head and neck with cisplatin and 5-fluorouracil
2. Structures of reversible and irreversible complexes of thymidylate synthase and fluorinated pyrimidine nucleotides
3. Adjuvant chemotherapy with cis-diamminedichloroplatinum II and 120-hour-infusion 5-fluorouracil in stage III and IV squamous cell carcinoma of head and neck
4. Enhanced DNA repair as a mechanism of resistance to cis-diamminedichloroplatinum(II)
5. Correlation between response to chemotherapy of human tumors in patients and in nude mice
6. Cisplatin plus 5-FU for the treatment of adenocarcinoma of the colon
7. DNA lesions in human neoplastic cells and cytotoxicity of 5-fluoropyrimidines
8. Progressive formation of DNA lesions during treatment with anti-metabolites without incorporation of the drugs into DNA
9. Increased DNA repair as a mechanism of acquired resistance to cis-diamminedichloroplatinum(II) in human ovarian cancer cell lines
10. Characterization of a newly established, TA-4-producing squamous carcinoma cell line derived from metastatic tongue carcinoma
11. 5-Fluorouracil-leucovorin and cisplatin sequential chemotherapy with dipyridamole for non-small cell lung cancer
12. Fluorouracil: biochemistry and pharmacology
13. Sequence dependence of the antitumor and toxic effects of 5-fluorouracil and cis-diamminedichloroplatinum combination on primary colon tumors in mice
14. Improved complete response rate and survival in advanced head and neck cancer after three-course induction therapy with 120-hour 5-FU infusion and cisplatin
15. Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells
16. cis-Dichlorodiammineplatinum(II): combination chemotherapy and cross-resistance studies with tumors of mice
17. 1-β- d-Arabinofuranosylcytosine and hydroxyurea production of cytotoxic synergy with cis-diammine-dichloroplatinum(II) and modification of platinum-induced DNA interstrand cross-linking